Breakthrough cancer pain: Rapid-onset opioids or short-acting opioids?
Published 28th April 2023
When selecting an appropriate opioid treatment for BTcP, it is important to consider the pharmacokinetic properties of the treatment.
Sign up to MediScene
To access this content, please register or log in.
Experience the full suite of Mediscene features such as:
References
- Davies AN et al. Eur J Pain 2009;13(4):331–8.
- Davies A et al. J Pain Symptom Manag 2013;46(5):619–28.
- Vellucci R et al. Drugs 2016;76:315–30.
- Simon SM et al. J Opioid Manag 2014;10:207–15.
- World Health Organization. Cancer Pain Relief. World Health Organization, 1986.
Available from: https://apps.who.int/iris/bitstream/handle/10665/43944/9241561009_eng.pdf - Smith HS. Ann Palliat Med 2012;1(1):45–52.